Sabra Health Care REIT (SBRA) FY2018 results: revenue $623 million, up 52.7% on the year
Sabra Health Care REIT, Inc. (SBRA) reported revenue of $623 million for fiscal 2018, the year ended 31 December 2018, up 52.7% on the year before. Net income was $279 million, up 76.2%, and diluted earnings per share $1.51. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2019.
Revenue
$623 million
+52.7% on the year
FY2011FY2018
Operating margin
n/a
FY2011FY2018
Net income
$279 million
+76.2% on the year
FY2011FY2018
Diluted EPS
$1.51
+7.9% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
623
408
261
+52.7%
Interest expense
147
88.4
64.9
+66.3%
Pre-tax income
288
159
71.3
+80.8%
Income tax
3.0
0.7
1.0
+362.5%
Effective tax rate
1.0%
0.4%
1.5%
Net income
279
158
70.3
+76.2%
Net margin
44.8%
38.8%
27.0%
Diluted EPS
$1.51
$1.40
$0.92
+7.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
361
136
176
+165.5%
Cash from investing
-258
-183
142
Cash from financing
-629
599
-301
Depreciation and amortisation
191
114
68.5
+68.1%
Share-based compensation
7.6
8.4
7.5
-8.5%
Dividends paid
325
182
119
+78.6%
Dividend per share
$1.80
$1.73
$1.67
+4.0%
Diluted shares, weighted
179m
106m
66m
+68.9%
Shares outstanding at period end
178m
178m
65m
+0.0%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
3,250
3,433
1,016
-5.3%
Non-controlling interest
4.3
4.4
0.0
-2.5%
Debt
3,232
3,394
1,211
-4.8%
Other liabilities
179
201
39.6
-11.0%
Total liabilities and equity
6,665
7,032
2,266
-5.2%
Intangible assets
131
167
26.2
-21.6%
Loans
69.5
65.9
50.8
+5.4%
Cash and equivalents
50.2
519
25.7
-90.3%
Other assets
6,415
6,281
2,163
+2.1%
Total assets
6,665
7,032
2,266
-5.2%
10-K for the year ended 31 December 2018, filed 25 February 2019: the filing.